Join us Thursday 4/24 at 2pm Central Time, as we focus on the valuation range for Ford (F). Register here. HIDE

Seattle Genetics (SGEN)

Add to Watchlists
Create an Alert
39.78 -1.09  -2.67% NASDAQ Apr 23, 3:59PM BATS Real time Currency in USD
View Full Chart
SGEN Price Chart
View All Events

SGEN Events

Date Type Description
May 01 Misc Seattle Genetics, Inc. Q1 2014 Earnings Conference Call
May 01 Earnings Seattle Genetics, Inc. Q1 2014 Earnings Results. Estimate: -0.20.
Feb 11 Misc Seattle Genetics, Inc. 4Q2013 Earning Conference Call
Feb 11 Earnings Seattle Genetics, Inc. 4Q2013 Earning Result. Estimate: -0.24.
Nov 05 Misc Seattle Genetics to Host Conference Call and Webcast Discussion of Third Quarter 2013 Financial Results on November 5, 2013
Nov 05 Earnings 3rd Quarter 2013 Financial Results. Estimate: -0.22.
Jul 31 Misc Seattle Genetics to Host Conference Call and Webcast Discussion of Second Quarter 2013 Financial Results on July 31, 2013
Jul 31 Earnings 2nd Quarter 2013 Financial Results. Estimate: -0.18.
May 07 Misc Seattle Genetics to Host Conference Call and Webcast Discussion of First Quarter 2013 Financial Results on May 7, 2013
May 07 Earnings Seattle Genetics to Host Conference Call and Webcast Discussion of First Quarter 2013 Financial Results on May 7, 2013. Estimate: -0.18.
View All Performance Charts

SGEN Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Seattle Genetics is up 3.86% over the last year vs S&P 500 Total Return up 22.59%, Actelion up 71.93%, and Roche Holding up 22.26%.

Get Quote for

PDF Report for SGEN

Download Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.

Download SGEN Pro Report PDF
Advertisement

Portfolio Strategies Featuring SGEN

Did Seattle Genetics make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

SGEN Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Headquarters Country: United States
  • Headquarters State/Province: Washington
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: June 30, 2014
  • Est. Current Fiscal Year End: December 31, 2014
  • Last Fiscal Quarter End: N/A
  • Last Fiscal Year End: N/A
  • NAICS: Biological Product (except Diagnostic) Manufacturing
  • NAICS Code: 325414
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Industry Code: 3254
  • NAICS Sector: Manufacturing
  • NAICS Sector Code: 32

Seattle Genetics, Inc., a clinical stage biotechnology company, focuses on the development and commercialization of monoclonal antibody-based therapies for the treatment of cancer and autoimmune diseases in the United States. The company was founded by Clay B. Siegall on July 15, 1997 and is headquartered in Bothell, Washington.

Recent Quotes

Symbol Price Chg Chg % Market Cap
SGEN 39.78 -1.09 -2.67% 4.892B
Create Watchlist from Quotes
Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start Your YCharts Membership. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{root.upsell.info.tier_name}} Member? Sign in here.